Clinical Trial

Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a prospective, multi-center, open-label, randomised controlled study. The purpose of this study is to evaluate the efficacy and safety of Huaier Granule versus SOX regimen in the postoperative adjuvant treatment of resectable stage II-III gastric cancer.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-08-11; most recent amendment 2024-06-20.
Status change: Recruiting → Not Yet Recruiting 2024-06-20
Status change: Not Yet Recruiting → Recruiting 2023-12-26
Trial Details
NCT Number NCT05498766
Lead Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators: LinkDoc Technology (Beijing) Co. Ltd.
Conditions Gastric Cancer
Enrollment 702 participants
Start Date 2024-07-01
Primary Completion 2029-07-01 (estimated)
Study Completion 2029-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-06-24